Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schostak

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Der Urologe. Ausg. A|October 26, 2012
[Long-term results for subcutaneous Detour® prosthesis for ureteral obstruction: experiences of implantation, aftercare and management of complications]A Janitzky, J Borski, M Porsch, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 6, 2008
Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevanceS Hinz, C Kempkensteffen, F Christoph, et al.
BMC Urology|March 17, 2006
Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancerM Schostak, H Krause, K Miller, et al.
Urologie (Heidelberg, Germany)|May 3, 2023
[Radiation-induced cataract-an occult risk for urologists]J J Wendler, J Schittko, A Lux, et al.
Urolithiasis|July 6, 2018
Impact of surgeon's experience on outcome parameters following ureterorenoscopic stone removalI Wolff, S Lebentrau, A Miernik, et al.
Der Urologe. Ausg. A|May 13, 2015
[Metastasized prostate cancer. Position paper on the use of chemotherapy]C-H Ohlmann, S Duensing, R Eichenauer, et al.
Der Urologe. Ausg. A|November 30, 2019
[Changes in the treatment of metastatic prostate cancer-new data and open questions]P Albers, M Bögemann, S Machtens, et al.
World Journal of Urology|September 21, 2004
Shared decision-making--results from an interdisciplinary consulting service for prostate cancerM Schostak, T Wiegel, M Müller, et al.
Aktuelle Urologie|November 4, 2008
[Testicular cancer - explanatory models for high cisplatin chemosensibility and new therapeutic options]J Ebbing, F Christoph, C Kempkensteffen, et al.
Aktuelle Urologie|November 8, 2007
[New polymorphisms in the PSA promoter in patients with prostate carcinoma]M Schostak, C Braun, H Krause, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Der Urologe. Ausg. A|October 26, 2012
[Long-term results for subcutaneous Detour® prosthesis for ureteral obstruction: experiences of implantation, aftercare and management of complications]A Janitzky, J Borski, M Porsch, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 6, 2008
Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevanceS Hinz, C Kempkensteffen, F Christoph, et al.
BMC Urology|March 17, 2006
Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancerM Schostak, H Krause, K Miller, et al.
Urologie (Heidelberg, Germany)|May 3, 2023
[Radiation-induced cataract-an occult risk for urologists]J J Wendler, J Schittko, A Lux, et al.
Urolithiasis|July 6, 2018
Impact of surgeon's experience on outcome parameters following ureterorenoscopic stone removalI Wolff, S Lebentrau, A Miernik, et al.
Der Urologe. Ausg. A|May 13, 2015
[Metastasized prostate cancer. Position paper on the use of chemotherapy]C-H Ohlmann, S Duensing, R Eichenauer, et al.
Der Urologe. Ausg. A|November 30, 2019
[Changes in the treatment of metastatic prostate cancer-new data and open questions]P Albers, M Bögemann, S Machtens, et al.
World Journal of Urology|September 21, 2004
Shared decision-making--results from an interdisciplinary consulting service for prostate cancerM Schostak, T Wiegel, M Müller, et al.
Aktuelle Urologie|November 4, 2008
[Testicular cancer - explanatory models for high cisplatin chemosensibility and new therapeutic options]J Ebbing, F Christoph, C Kempkensteffen, et al.
Aktuelle Urologie|November 8, 2007
[New polymorphisms in the PSA promoter in patients with prostate carcinoma]M Schostak, C Braun, H Krause, et al.
Pageof 9